Announcement on Subsidiary's Vecuronium Bromide for Injection Passing Generic Drug Consistency Evaluation

About this update from Lionco Pharmaceutical Group Co., Ltd. Class A

Announcement on Subsidiary's Vecuronium Bromide for Injection Passing Generic Drug Consistency EvaluationThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Lionco Pharmaceutical Group Co., Ltd. Class A